Ran Frenkel Net Worth & Insider Trades

Ran Frenkel - EVP, Karyopharm Therapeutics Inc

As of March 2, 2022

What is Ran Frenkel's Net Worth?

The current estimated net worth of Karyopharm Therapeutics Inc's EVP, Ran Frenkel, is estimated to be about $512.47K . Ran Frenkel owns about 168,290 units of Karyopharm Therapeutics Inc common stock. In the last 8 years at Karyopharm Therapeutics Inc, Ran Frenkel has sold an estimated value of $324.29K worth.

What is Ran Frenkel's Past Insider Trading?

Ran Frenkel's largest purchase order was 3,000 units , worth over $95.43K on April 8, 2015. Ran Frenkel's largest sale order was 4,958 units , worth over $55.76K on November 9, 2017. In total, Ran Frenkel has made about 22 transactions over 8 years of their time at Karyopharm Therapeutics Inc. Ran Frenkel usually trades in February, with the busiest year in 2021 and 2020. The most recent transaction was a sale order of 1,663 units , worth over $17.03K on March 2, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Ran Frenkel's' Mailing Address?

  • Mailing address is C/o Karyopharm Therapeutics Inc. 85 Wells Avenue, 2nd Floor Newton MA 02459 MA

What are Karyopharm Therapeutics Inc's Past Insider Trades?

Karyopharm Therapeutics Inc's most recent insider trade came on January 5, 2023 by Richard Paulson who sold 3,922 units worth $12.82K . In the last 10 years, insiders at Karyopharm Therapeutics Inc have sold an estimated value of $147.85M and bought an estimated value of $33.44M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Sharon Shacham, Chief Scientific Officer,  Michael Kauffman, Director,  and Andreas Hadjimichael .

Karyopharm Therapeutics Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1